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ABSTRACT 
Portacaval anastomosis (PCA) is a surgical procedure whereby blood from the portal vein is shunted into the inferior vena 
cava. PCA in the rat results in a significant increase (from 0.77 ± 0.26 to 3.51 ± 0.37 g of ethanol/kg/day) in voluntary 
ethanol consumption in a free- choice paradigm between water and 5% ethanol solution. After PCA surgery, increased 
voluntary ethanol consumption starts abruptly at 6 to 7 days and is maintained for >28 weeks. Voluntary ethanol 
consumption in rats after PCA results in blood ethanol levels up to 158 mg%. After PCA, the ethanol preference ratio 
(defined as the percentage of total fluid intake constituted by ethanol) increased from 19 ± 2% to 78 ± 2% (p < 0.001). 
Administration of the nonselective opioid receptor antagonist naloxone (5 mg/kg, sc) resulted in a significant 6-fold 
attenuation of voluntary ethanol consumption by rats with PCA, an effect that was not mediated by an effect on locomotor 
activity. These findings, together with previous reports of wide- spread alterations of the p- and 6-opioid receptors in the 
brain after PCA, suggest that increased voluntary ethanol consumption and ethanol preference in PCA rats may result from 
activation of the endogenous opioid system. Preliminary studies suggest that rats with PCA manifest behavioral signs 
consistent with the development of dependence. The portacaval-shunted rat may provide a useful preparation for the study 
of mechanisms, in particular those involving the liver, implicated in the development of increased voluntary ethanol 
consumption and ethanol preference.  
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INTRODUCTION 
CHRONIC LIVER disease of either alcoholic or non-alcoholic etiology invariably results in the formation of portal-
systemic shunts as a result of the increase in portal pressure. This portal-systemic shunting frequently results in a complex 
neuropsychiatric syndrome known as portal- systemic encephalopathy (PSE)(1), with associated changes in brain 
biochemistry. Increased voluntary ethanol consumption, in a free-choice two-bottle paradigm, has been reported in rats after 
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portacaval shunting(2,3) and in rats with carbon tetrachloride(CCL4)-induced cirrhosis4). This finding was surprising, 
because it is well known that studies of ethanol consumption in the laboratory rat are limited by the innate aversion of rats 
to ethanol. It is possible that the increase in voluntary ethanol consumption in rats after portacaval shunting may result from 
alterations in brain biochemistry; such changes include amino acids(6), monoamine(7,8), or opioid peptides.(9,10) With 
regard to the latter, there is substantial evidence to suggest that the endogenous opioid system of the brain is one of the 
major neuronal systems involved in the media- tion of increased ethanol consumption. Similarities exist between some of 
the physiological effects of ethanol and opiates.(11) Administration of nonselective opiate antagonists, such as naloxone(12-
14) and naltrexone (12-14) and of the selective δ-opioid receptor antagonists IC1-174864 (15) and naltrindole(16) lead to 
reductions in voluntary ethanol consumption in rodents. Furthermore, naltrexone has been used in clinical studies for the 
treatment of ethanol dependence in humans (17,18). Ethanol stimulates the in vitro release of β-endorphin (β-EP) from rat 
pituitary(19) and hypothalamic(20) preparations, and differences in hypothalamic β-EP release have been demonstrated 
between ethanol- preferring and ethanol-avoiding strains and lines of animal(21-23). 
Previous studies have revealed alterations of the endogenous opioid system in patients with liver disease (24,25) and in an 
animal model of PSE (26) as well as in CC14,-induced cirrhosis(27). Recently, we reported that portacaval anastomosis 
(PCA) in the rat induces alterations in the β-EP system of the brain, as well as in μ- and δ-opioid receptors(10). Four weeks 
after PCA surgery, quantitative autoradiographic studies using selective radioligands revealed that ethanol-naive PCA rats 
manifest significant changes in the densities of opioid binding sites in nuclei of the limbic system known to modulate the 
rewarding and the positive- reinforcing effects of many drugs of abuse, including ethanol(18). The aim of the present study 
was to characterize further the increase in voluntary ethanol consumption by rats after PCA. Ethanol consumption, in a free-
choice paradigm be- tween 5% ethanol and water, was monitored before and after either PCA or sham operation (control). 
The time come of the development of ethanol preference with respect to PCA surgery time and with respect to day time and 
night time activity patterns was also assessed. To evaluate the implication of the endogenous opioid system in the increased 
voluntary ethanol consumption by PCA rats, effects of the opioid antagonist naloxone was studied on both ethanol intake 
and locomotor activity. Preliminary assessment of dependence on ethanol was made by monitoring relapse to ethanol 
consumption after episodes of withdrawal. 
MATERIALS AND METHODS  
Male Sprague-Dawley rats weighing 250 to 300 g (Charles River, St.-Constant, Québec) were housed singly under a 12-hr 
light/dark cycle (lights on at 06:00 AM and lights off at 06:00 PM), with food (Purina Lab Chow) and water available ad 
libitum. After a 24-hr acclimatization period, the animals were given the choice between two identical drinking bottles: one 
containing 100 ml of tap water and the other containing 100 mI of a 5% ethanol solution, made up of 95% ethanol diluted 
with tap water. The two drinking bottles were surrounded by food pellets to avoid any food-related preference bias. For 
similar reasons, the position of the two drinking bottles in the home cage was changed every day. The volume of liquid 
consumed and the animals’ body weight were monitored daily.  
After 2 weeks of ethanol exposure, rats underwent a laparotomy under halothane anesthesia, and an end-to-side portacaval 
anastomosis was performed as previously decribed.(29). Surgery time was under 15 min. For sham operation, after 
laparotomy, the portal vein and vena cava were clamped for 15 min. Animals were returned to their home cage with food 
available ad libitum and the choice between water and the 5% ethanol solution. Body weight, as well as water and ethanol 
consumption, were monitored daily for a period of 5 weeks postsurgery. Six weeks after PCA surgery, the concentration of 
the ethanol solution was increased to 10% for the PCA rats.  
ACUTE EFFECTS OF NALOXONE ON ETHANOL CONSUMPTION  
The effects of naloxone were studied after 5 weeks of voluntary 5% ethanol consumption by PCA rats versus sham-operated 
controls. Ethanol and water were presented in a two-bottle free-choice paradigm, with food and liquid available ad libitum. 
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Before the administration of either saline or naloxone, ethanol consumption was monitored on consecutive days between 
06:00 and 09:00 PM and between 09:00 and 11:00 PM (lights-off period). NaIoxone-HCI (Sigma Chemical Co., St. Louis, 
MO) was diluted in sterile saline to afford a stock solution of 50 mg naloxone/ml. The stock solution was diluted with saline 
and administered subcutaneously at a final dose of 5 mg of naloxone/kg of body weight. The day before naloxone 
administration, animals were administered an equivalent volume of sterile saline subcutaneously to control for the effects of 
injection stress. Ethanol consumption was monitored for 180 and 300 min after the administration of saline or naloxone, and 
compared with ethanol consumption measured in the absence of either saline or naloxone.  
BEHAVIORAL TESTING 
 Animals were transferred to an isolated room equipped with an Opto-Varimex activity monitor coupled to an Auto-Track 
system (Columbus Instruments, Columbus, OH) for a period of five consecutive days, under a 12-hr light cycle (lights on at 
06:00 AM and lights off at 06:00 PM), with food, water, and 5% ethanol available ad libitum. Locomotor activity of the 
animals was monitored during the lights-off period on each day. The activity of the animals measured on days 2 and 3 was 
used to define the normal (baseline) of the animals. On day 4, just before the onset of the lights-off period, rats were 
administered a single injection of saline, whereas on day 5, they received a single injection of naloxone (5 mg/kg sc).  
DETERMINATION OF BLOOD ETHANOL LEVELS  
Tail blood (20 μL) was collected at various time intervals and was immediately deproteinized in 180 μl of 6.25% 
trichloroacetic acid. Ethanol content was determined enzymatically by the oxidation of ethanol to acetaldehyde coupled to 
the reduction of NAD to NADH (Sigma Diagnostics Kit 332-UV, Sigma).  
PRELIMINARY ASSESSMENT OF ETHANOL DEPENDENCE 
Two approaches were used to determine whether PCA rats developed signs of ethanol dependence. First, ethanol was 
withdrawn for periods of 1,3, or 8 days, with the ethanol solution being replaced by water; there was 1 week of ethanol 
availability between each withdrawal session. Voluntary ethanol consumption was monitored during the lights-on period, 
between 10:00 AM and noon, before ethanol withdrawal, and at the same time period after re-exposure to ethanol. The 
behavior of the animals was monitored for signs of ethanol withdrawal. In a second experiment, the effect of 3 days ethanol 
withdrawal was monitored 2 hr after onset of the lights-off period.  
STATISTICAL ANALYSIS 
For statistical evaluation of the data, one- or two-way repeated measures ANOVAs, followed by the Newman-Keuls or 
Dunnet post-hoc tests, were used for multiple group comparisons. The unpaired Student’s t test for two group comparisons 
was also used; p ≤0.05 was considered to be statistically significant. The nonparametric Mann Whitney U test was used in 
the naloxone experiment, with p ≤0.05 considered to be statistically significant.  
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RESULTS 
Figure 1 shows the effects of PCA on voluntary ethanol 
consumption in the rat. PCA had no effect on the total 
volume of liquid consumed by the animals, which was 
maintained in the 72 to 81 ml/kg of body weight/day 
range for the duration of the experimental period. PCA 
induced an 11% decrease in body weight during the 
first 2 weeks postsurgery, which was followed by a 
gradual increase in body weight (data not shown), so 
that 2 weeks postsurgery, weight gain curves for the 
animals in the shunted group were not significantly 
different from sham-operated controls. Results of 
ethanol consumption are expressed as the ethanol 
preference ratio (volume of ethanol solution/total 
volume of fluid consumed) to assess the development 
of ethanol preference in PCA rats. This ratio was not 
significantly modified by sham operation. Before PCA 
surgery, 19 ± 2% of the rats’ total fluid intake 
constitued ethanol solution (1.93 ± 0.25 ml/kg of body 
weight/day). PCA led to an increase in this ratio to 78 ± 
2% (6.5 ± 0.34 ml/kg of body weight/day), 4 weeks 
after surgery. A two-way ANOVA with treatment and 
time as independent variables demonstrated a 
significant effect of treatment [F(1,44) = 50.12 ; p < 
0.001] and time [F(4,44) = 45;p < 0.001]. These significant increases in ethanol preference ratio in PCA rats were 
manifested at weeks 2, 3, and 4 after PCA (p < 0.05, Newman-
Keuls test). There was no difference in ethanol consumption 
with time in sham-operated control rats. The level of ethanol 
consumption after PCA resulted in mean blood ethanol levels, 
measured 3 hr after the onset of the lights-off period, of 40 
mg% (range: 3 to 158 mg%). In parallel with the change in 
ethanol preference ratio, there was a significant increase in the 
total amount of ethanol consumed daily by PCA rats, which 
showed a positive correlation between volume of ethanol 
consumed and day of treatment (Spearman’s r = 0.648; p < 
0.001). Sham- operated control rats maintained a low but stable 
consumption of ethanol throughout the duration of the study 
(Spearman’s r = 0.017; p = 0.789) (Fig. 1).  
 
The increase in ethanol consumption in rats after PCA took 6 to 
7 days to develop, as demonstrated in Fig. 2. After a sharp 
increase, ethanol consumption increased steadily for three consecutive weeks, as shown in Fig. 1. A one-way repeated-
measures ANOVA followed by the Dunnet’s test demonstrated a significant effect of time [F(22,160) = 6.94; p < 0.001]. 
Daily ethanol consumption by PCA rats then stabilized 4 weeks after surgery and remained at comparable levels for up to 
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28 weeks. Similar levels of ethanol consumption were observed when ethanol concentration was doubled to 10% (3.51 ± 
0.37 g/kg of body weight/day). At this time, the PCA rats consumed 59% of their ethanol during the lights-off period.  
The effects of saline or naloxone administration (5 mg/kg sc) on 
voluntary ethanol consumption in rats 5 weeks after PCA or 
sham operation are presented in Fig. 3. Administration of 
naloxone resulted in a significant (p < 0.01, Student’s t test) 
decrease in voluntary ethanol consumption in PCA rats, but not 
in sham-operated control rats (p > 0.1, Student’s t test or p > 
0.08, Mann Whitney nonparametric U test). This decrease in 
voluntary ethanol consumption in rats with PCA was still present 
5 hr after administration of naloxone, a period that represents 
approximately twice the biological half-life of the antagonist.  
 The effects of saline and naloxone on locomotor activity in PCA 
rats are presented in Table 1. Locomotor activity increased in the 
hours after the onset of the dark period as expected. Although the 
animals were more active after saline injection than in basal 
conditions, this difference was not statistically significant (p > 
0.1, Student’s t test). Administration of naloxone (5 mg/kg sc) 




During withdrawal from ethanol, PCA rats showed signs of 
withdrawal such as teeth chattering, piloerection, vocalization, and 
aggressivity when handled, even though the animals had been handled 
daily for 7 weeks. After periods of withdrawal, there was an 
immediate relapse to increased voluntary ethanol consumption (Fig. 
4A). When access to ethanol was resumed by replacing the water of 
one of the two drinking bottles by ethanol, all PCA rats resumed 
drinking within 1 min, after a minimum of exploratory, mainly 
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olfactory, behavior. A one-way ANOVA shows a significant effect of time of withdrawal [F(3,40) = 9.844, p < 0.001]. The 
effects of 3 and 8 days of withdrawal on ethanol consumption were similar (p > 0.1, Newman-Keuls), and blood ethanol 
levels reached 30 ± 10 mg% at the end of the experimental period. Similar results were observed when ethanol consumption 
was measured during the first 2 hr of the lights-off period (Fig. 4B). However, in both cases, there was no significant 






Results of the present study demonstrate that rats develop increased ethanol preference and increased consumption within 7 
days of PCA, and that this increased voluntary ethanol consumption is sustained for several months. PCA rats orally self-
administer pharmacologically significant amounts of ethanol in a free-choice paradigm, producing blood ethanol levels up 
to 158 mg%. They develop a preference for ethanol solution over drinking water and show behavioral signs suggestive of 
ethanol dependence. These results confirm and extend previous observations of increased ethanol consumption by rats after 
PCA.(2,3) Because, in the present studies, the positions of ethanol and water bottles were alternated every day, development 
of a position preference bias in either the PCA or sham-operated control rats was eliminated. Both the ethanol preference 
ratio (defined as the percentage of total fluids consumed in the form of ethanol) and total ethanol consumption remained at 
low values in the sham-operated control group. In contrast, the volume of ethanol consumed by the PCA rats increased 2-
fold (from 0.77 ± 0.26 to 1.49 ± 0.26 g/kg of body weight/day), and the ethanol preference ratio increased 4-fold within 7 
days of surgery. Mean voluntary ethanol consumption, with free access to water and food, by the selectively bred alcohol-
preferring P and AA lines of rats, are reportedly in the 5 to 7 g of ethanol/kg of body weight/day range, a pattern of 
consumption that produces blood ethanol levels as high as 100 mg%.(30,31). PCA rats consume less ethanol than these 
selectively bred ethanol-preferring rats, an observation that may result from the fact that genetic selection, either by in- 
breeding or by selective breeding, could induce an exacerbation of the selected trait (32), thus resulting in an exceedingly 
high amount of ethanol consumed by these animals. However, preliminary findings in the present study suggest that PCA 
rats do develop neurobehavioral signs consistent with physical dependence on ethanol suggest that PCA rats do develop 
neurobehavioral signs consistent with physical dependence on ethanol. For example, signs of withdrawal, corresponding to 
stages I1 to IV of withdrawal,(33) were observed when the ethanol solution was removed from PCA rats after 5 weeks of 
continuous ethanol exposure. Other indications of the possible development of physical dependence is the observation that 
PCA rats respond to a period of ethanol deprivation by a significant increase in ethanol consumption when unrestricted 
access is reinstated, a behavior previously reported both in ethanol-dependent animals(34) and in humans.(35) In the present 
study, the volume of ethanol consumed was monitored both between 10:00 AM and noon, when normal animals are inactive 
and when ethanol consumption would normally be minimal, and also during the 2 hr after the onset of the lights-off period. 
The volume of ethanol consumed during the 2-hr period of lights-on, after reinstatement of ethanol exposure after 3 or 8 
days of withdrawal, represents a 5- to 10-fold increase in the amount of ethanol normally consumed during the 10:00 AM to 
noon period. Similarly, the PCA rats respond to periods of withdrawal by a significantly higher level of ethanol 
consumption during the 2-hr period after reinstatement of ethanol, at the onset of the lights-off period after 3 days of 
withdrawal (Fig. 4B). In both cases, the increased ethanol consumption is restricted to the first 2 hr after ethanol 
reinstatement, whereas no significant difference is observed in the total volume of ethanol consumed during the 24-hr 
period after reinstatement of ethanol, compared with the total ethanol intake for 24 hr before withdrawal episodes.  
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The increase in voluntary ethanol consumption by rats after PCA may result from alterations in the activity of the 
endogenous opioid system(10). In favor of such a mechanism, previous reports describe significant increases in the density 
of δ-opioid receptors in the nucleus accumbens of ethanol-naive PCA rats, compared with sham-operated controls (10), and 
increased densities of δ-opioid receptors have been described in the nucleus accumbens of ethanol-naive alcohol-preferring 
AA rats, compared with alcohol-avoiding as well as in preliminary studies of the P rats compared with NP rats(37) and for 
the C57BL/6 (alcohol-preferring) compared with the DBN2 (alcohol-avoiding) inbred strains of mice.(38) The rewarding 
effects of ethanol and other drugs of abuse are mediated by the release of dopamine from the terminal fields of the A10 
dopaminergic system located in the nucleus accumbens(39,40) and ethanol-induced release of dopamine in the nucleus 
accumbens of Sprague-Dawley rats has been demonstrated in vivo.(28,41) Microdialysis studies demonstrate that focal 
injection into the nucleus accumbens of [D-Ala-2] deltorphin II, a δ-receptor (42) blocked the ethanol-induced release of 
dopamine in the nucleus accumbens, suggesting that δ-receptors in the nucleus accumbens play a major role in the 
mediation of the positive-reinforcing effects of ethanol and thus in the control of voluntary ethanol consumption. These 
observations suggest that increased ethanol preference in PCA rats may be mediated, at least in part, by the endogenous 
opioid system, a suggestion that is further supported by the observation, in the present studies, of a significant reduction in 
ethanol intake after the administration of the nonspecific opioid receptor antagonist naloxone to these animals (Fig. 3). 
Previous studies suggest that naloxone induces a reduction in motor and one could argue that this may have been 
responsible for the decrease in ethanol consumption in the present study. However, this does not seem to be the case, 
because there were no differences in locomotor activity of PCA rats in the absence and presence of naloxone (Table l), 
although there was a transitory increase in locomotor activity after the injection of saline alone, which probably resulted 
from injection stress. Thus, the observed decrease in voluntary ethanol consumption in PCA rats could be attributable to the 
blockade of opioid receptors, preventing the mediation of the positive-reinforcing effects of ethanol in these animals. 
Further studies using selective antagonists to both p- and S-opioid receptor subtypes are required to elucidate further the 
precise nature of the role of the opioid system in the modulation of increased ethanol consumption and preference by PCA 
rats.  
The PCA rat model may facilitate the study of molecular mechanisms responsible for the initiation and development of 
ethanol preference and consumption in the same animal, irrespective of genetic predisposition. Furthermore, a careful 
examination of the biochemical changes occurring during the first 2 weeks after PCA, in relation to the development of 
increased voluntary ethanol consumption, may provide new insights into the role of neurotransmitter and/or neuropeptide 
systems involved in the development of alcohol preference and increased ethanol consumption. The observation that PCA 
induces an increase in voluntary ethanol consumption raises the possibility that some forms of excessive ethanol 
consumption may be the result of liver dysfunction, and that individuals with alcoholic or nonalcoholic liver disease may be 
susceptible to the development of hazardous drinking.  
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